Outsmarting the Heart at ISHLT 2025 At our ISHLT 2025 symposium, a multi-disciplinary faculty discussed unmet needs with guideline directed medical... Read More
Device Therapy Targeting the Neurohormonal Pathway in Heart Failure Patients Barostim is a novel device therapy that works with guideline-directed medical therapy and targets the... Read More
Integrating Barostim into a Comprehensive Heart Failure Program at ISHLT 2024 Did you miss our symposium at ISHLT 2024? Watch the recordings to hear an expert faculty panel featuring Drs.... Read More